Skip to content

short term outcomes of naloxone in neonatal resuscitation

short term outcomes of naloxone in neonatal resuscitation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20170211001
Enrollment
Unknown
Registered
2017-02-11
Start date
2016-01-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

death tachycardia hypertension arrhythmia vomitting seizure length of stay naloxone side effect lengthof stay

Interventions

naloxone
Treatment

Sponsors

facultyof medicine Ramathibodi hospital, Mahidol univerysity
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: infant who was administrated naloxone during neonatal resuscitation.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
side effect of naloxone in infant resuscitated with naloxone 24hour after injection review from medical record

Secondary

MeasureTime frame
N/A N/A N/A

Countries

Thailand

Contacts

Public Contactkullapat Srisomsap

none

kallaput@hotmail.com0816844342

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026